Efficacy endpoints included the time-weighted average change from baseline in the WOMAC VA @ Pain Subscale ( @ mm Visual Analog Scale -LSB- VAS -RSB- ; primary endpoint ) , the WOMAC VA @ Physical Function Subscale ( @ mm VAS ) , and Patient Global Assessment of Disease Status ( PGAD ) ( @ mm VAS ) .